Credit Suisse analyst Grant Joslin initiates coverage on Frontier Communications (NASDAQ:FYBR) with a Neutral rating and announces Price Target of $25.
Morgan Stanley analyst Andrew Galler initiates coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Equal-Weight rating and announces Price Target of $41.